Clinical Trial Update: A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate RO7204239 on insulin sensitivity and muscle composition in adults with Type 2 Diabetes Mellitus and overweight/obesity; the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• RO7204239

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Type 2 Diabetes Mellitus, Obesity | Phase 1 | Status: ACTIVE_NOT_RECRUITING